Table 4.
Parameters | WBC group | KT group | P | |
---|---|---|---|---|
FRAP (μmol/l) |
Before | 646.1 ± 146.0 | 639.4 ± 83.8 | 0.876 |
After | 727.1 ± 114.4 | 609.9 ± 90.4 | 0.003 | |
P ∗ | <0.001 | 0.088 | ||
Δ | 81.0 ± 59.6 | −29.5 ± 78.9 | <0.001 | |
| ||||
PSH (s) (μmol/l) |
Before | 613.2 ± 323.1 | 481.4 ± 126.8 | 0.145 |
After | 588.6 ± 312.7 | 451.4 ± 137.0 | 0.123 | |
P ∗ | 0.438 | 0.087 | ||
Δ | −24.6 ± 170.1 | −30.1 ± 163.2 | 0.926 | |
| ||||
UA (s) (mg/dl) |
Before | 5.33 ± 1.50 | 5.61 ± 0.86 | 0.513 |
After | 5.47 ± 1.26 | 5.31 ± 1.24 | 0.720 | |
P ∗ | 0.352 | 0.198 | ||
Δ | 0.15 ± 0.85 | −0.30 ± 0.88 | 0.154 |
P: statistical significance of differences between both groups of patients; P∗: statistical significance of differences between values before and after treatment in particular groups of patients. (p): plasma; (s): serum; Δ: difference prior to posttreatment.